FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1515065013> ?p ?o ?g. }

• W1515065013 endingPage "470" @default.
• W1515065013 startingPage "463" @default.
• W1515065013 abstract "We conducted a phase II study of the AKT inhibitor, MK2206 in patients with relapsed or refractory lymphoma of any histology excluding Burkitt lymphoma or lymphoblastic lymphoma. MK-2206 was administered orally at 200 mg once weekly in 28-d cycles up to 12 cycles in the absence of progression or significant toxicity. The dose was adjusted based on tolerance. A total of 59 patients were enrolled. The final doses patients received were 300 mg (n = 33), 250 mg (n = 2), 200 mg (n = 16) and 135 mg (n = 8). Based on intent-to-treat analysis, objective response was observed in 8 (14%) patients (2 complete response and 6 partial response), with median response duration of 5·8 months. The overall response rate was 20% in 25 patients with classical Hodgkin lymphoma. Rash was the most common toxicity (any grade 53%, Grade 3 in 15%) and was observed in a dose-dependent manner. The correlative cytokine analysis showed paradoxical increase in several cytokines, which may be explained by negative feedback mechanism induced by the on-target effect of AKT inhibitor. Our data demonstrate that MK2206 has a favourable safety profile with a modest activity in patients with relapsed Hodgkin lymphoma. The future studies should explore mechanism-based combinations (clinicaltrials.gov NCT01258998)." @default.
• W1515065013 created "2016-06-24" @default.
• W1515065013 creator A5028677309 @default.
• W1515065013 creator A5037784199 @default.
• W1515065013 creator A5044284041 @default.
• W1515065013 creator A5060924118 @default.
• W1515065013 creator A5064752432 @default.
• W1515065013 creator A5065054247 @default.
• W1515065013 creator A5068152076 @default.
• W1515065013 creator A5070455368 @default.
• W1515065013 creator A5074654320 @default.
• W1515065013 creator A5074743570 @default.
• W1515065013 creator A5085712310 @default.
• W1515065013 creator A5089736242 @default.
• W1515065013 date "2015-07-27" @default.
• W1515065013 modified "2023-10-12" @default.
• W1515065013 title "Phase II study of an AKT inhibitor MK2206 in patients with relapsed or refractory lymphoma" @default.
• W1515065013 cites W1966271071 @default.
• W1515065013 cites W1977267072 @default.
• W1515065013 cites W2019874087 @default.
• W1515065013 cites W2027114592 @default.
• W1515065013 cites W2034847306 @default.
• W1515065013 cites W2036691369 @default.
• W1515065013 cites W2038444072 @default.
• W1515065013 cites W2047257824 @default.
• W1515065013 cites W2049517768 @default.
• W1515065013 cites W2060346337 @default.
• W1515065013 cites W2070073293 @default.
• W1515065013 cites W2087693130 @default.
• W1515065013 cites W2105549867 @default.
• W1515065013 cites W2107781239 @default.
• W1515065013 cites W2130883918 @default.
• W1515065013 cites W2133201432 @default.
• W1515065013 cites W2134861285 @default.
• W1515065013 cites W2136269815 @default.
• W1515065013 cites W2146414563 @default.
• W1515065013 cites W2152127926 @default.
• W1515065013 cites W2159750196 @default.
• W1515065013 cites W2160009436 @default.
• W1515065013 cites W2168554267 @default.
• W1515065013 cites W2169064989 @default.
• W1515065013 cites W2276310429 @default.
• W1515065013 cites W2388163742 @default.
• W1515065013 cites W2554039459 @default.
• W1515065013 cites W2569622270 @default.
• W1515065013 cites W2589824760 @default.
• W1515065013 cites W2979839758 @default.
• W1515065013 cites W2980183364 @default.
• W1515065013 doi "https://doi.org/10.1111/bjh.13603" @default.
• W1515065013 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5278973" @default.
• W1515065013 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/26213141" @default.
• W1515065013 hasPublicationYear "2015" @default.
• W1515065013 type Work @default.
• W1515065013 sameAs 1515065013 @default.
• W1515065013 citedByCount "72" @default.
• W1515065013 countsByYear W15150650132015 @default.
• W1515065013 countsByYear W15150650132016 @default.
• W1515065013 countsByYear W15150650132017 @default.
• W1515065013 countsByYear W15150650132018 @default.
• W1515065013 countsByYear W15150650132019 @default.
• W1515065013 countsByYear W15150650132020 @default.
• W1515065013 countsByYear W15150650132021 @default.
• W1515065013 countsByYear W15150650132022 @default.
• W1515065013 countsByYear W15150650132023 @default.
• W1515065013 crossrefType "journal-article" @default.
• W1515065013 hasAuthorship W1515065013A5028677309 @default.
• W1515065013 hasAuthorship W1515065013A5037784199 @default.
• W1515065013 hasAuthorship W1515065013A5044284041 @default.
• W1515065013 hasAuthorship W1515065013A5060924118 @default.
• W1515065013 hasAuthorship W1515065013A5064752432 @default.
• W1515065013 hasAuthorship W1515065013A5065054247 @default.
• W1515065013 hasAuthorship W1515065013A5068152076 @default.
• W1515065013 hasAuthorship W1515065013A5070455368 @default.
• W1515065013 hasAuthorship W1515065013A5074654320 @default.
• W1515065013 hasAuthorship W1515065013A5074743570 @default.
• W1515065013 hasAuthorship W1515065013A5085712310 @default.
• W1515065013 hasAuthorship W1515065013A5089736242 @default.
• W1515065013 hasBestOaLocation W15150650132 @default.
• W1515065013 hasConcept C121332964 @default.
• W1515065013 hasConcept C126322002 @default.
• W1515065013 hasConcept C142424586 @default.
• W1515065013 hasConcept C143998085 @default.
• W1515065013 hasConcept C2778570526 @default.
• W1515065013 hasConcept C2779338263 @default.
• W1515065013 hasConcept C29730261 @default.
• W1515065013 hasConcept C31760486 @default.
• W1515065013 hasConcept C71924100 @default.
• W1515065013 hasConcept C87355193 @default.
• W1515065013 hasConcept C90924648 @default.
• W1515065013 hasConceptScore W1515065013C121332964 @default.
• W1515065013 hasConceptScore W1515065013C126322002 @default.
• W1515065013 hasConceptScore W1515065013C142424586 @default.
• W1515065013 hasConceptScore W1515065013C143998085 @default.
• W1515065013 hasConceptScore W1515065013C2778570526 @default.
• W1515065013 hasConceptScore W1515065013C2779338263 @default.
• W1515065013 hasConceptScore W1515065013C29730261 @default.
• W1515065013 hasConceptScore W1515065013C31760486 @default.
• W1515065013 hasConceptScore W1515065013C71924100 @default.

• next